PULMATRIX, INC. Effective Tax Rate
PULMATRIX, INC. (PULM) reported Effective Tax Rate of 0.00% for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-23.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2021-03-23
- PULMATRIX, INC. effective income tax rate reconciliation, percent for the quarter ending 2016-03-31 was 39.28%.
- PULMATRIX, INC. effective income tax rate reconciliation, percent for fiscal 2020 was 0.00%.
- PULMATRIX, INC. effective income tax rate reconciliation, percent for fiscal 2019 was 0.00%.
- PULMATRIX, INC. effective income tax rate reconciliation, percent for fiscal 2018 was 0.00%.
- PULMATRIX, INC. effective income tax rate reconciliation, percent for fiscal 2017 was 0.00%, a 100.00% decline from fiscal 2016.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed |
|---|---|---|---|---|---|
| 2020-12-31 | 0.00% 10-K · filed 2021-03-23 | ||||
| 2019-12-31 | 0.00% 10-K · filed 2021-03-23 | ||||
| 2018-12-31 | 0.00% 10-K · filed 2020-03-26 | ||||
| 2017-12-31 | 0.00% 10-K · filed 2019-02-19 | ||||
| 2016-12-31 | 9.60% 10-K · filed 2018-03-13 | ||||
| 2016-06-30 | 39.28% 10-Q · filed 2016-08-04 | ||||
| 2016-03-31 | 39.28% 10-Q · filed 2016-05-05 | ||||
| 2015-12-31 | 0.00% 10-K · filed 2017-03-10 | 39.28% 10-K · filed 2016-03-10 | |||
| 2015-09-30 | 39.28% 10-Q · filed 2015-11-12 | ||||
| 2015-06-30 | 39.28% 10-Q · filed 2015-08-14 | ||||
| 2015-03-31 | 0.00% 10-K · filed 2015-06-10 | ||||
| 2014-12-31 | 0.00% 10-K · filed 2016-03-10 | ||||
| 2014-03-31 | 0.00% 10-K · filed 2015-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |